Art

J-GLOBAL ID：201902224725050189   Reference number：19A1290564

Social Interaction Improved by Oxytocin in the Subclass of Autism with Comorbid Intellectual Disabilities

共存する知的障害を伴う自閉症のサブクラスにおけるオキシトシンにより改善された社会的相互作用【JST・京大機械翻訳】

Author (6)： Higashida Haruhiro (Research Center for Child Mental Development, Kanazawa University, Kanazawa 920-8640, Japan) ,  Munesue Toshio (Research Center for Child Mental Development, Kanazawa University, Kanazawa 920-8640, Japan) ,  Kosaka Hirotaka (Department of Neuropsychiatry, Graduate School of Medical Sciences and Research Center for Child Mental Development, University of Fukui, Eiheiji 910-1193, Japan) ,  Yamasue Hidenori (Department of Psychiatry and Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan) ,  Yokoyama Shigeru (Research Center for Child Mental Development, Kanazawa University, Kanazawa 920-8640, Japan) ,  Kikuchi Mitsuru (Research Center for Child Mental Development, Kanazawa University, Kanazawa 920-8640, Japan)
Material： Diseases (Web)
Volume： 7  Issue： 1  Page： 24  Publication year： 2019 
JST Material Number： U7174A  ISSN： 2079-9721  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Approximately half of all auti...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1290564&from=J-GLOBAL&jstjournalNo=U7174A") }}

Thesaurus term： drug therapy ,  therapy ,  Epilepsy ,  *intelligence disorder ,  seizure (disease) ,  *autism ,  side effect ,  human ,  randomized controlled trial ,  *Oxytocin ,  placebo ,  administration (biology) ,  juvenile ,  adverse reaction ,  comorbidities
Semi thesaurus term： 日常生活 ,  有害事象 ,  共存罹患 ,  自閉症スペクトラム障害 , 【Automatic Indexing@JST】

Author keywords (6)： autism ,  oxytocin ,  subclasses ,  intellectual disability ,  epilepsy ,  randomized controlled trial

JST classification (2)： Mental disorders  (GR03000A) ,  Drug therapy(=pharmacotherapy)for mental disorders  (GR04020D)

Reference (83)：

• Lai, M.C.; Lombardo, M.V.; Baron-Cohen, S. Autism. Lancet 2014, 383, 896-910.
• Elsabbagh, M.; Divan, G.; Koh, Y.J.; Kim, Y.S.; Kauchali, S.; Marcín, C.; Montiel-Nava, C.; Patel, V.; Paula, C.S.; Wang, C.; et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res. 2012, 5, 160-179.
• Richards, C.; Jones, C.; Groves, L.; Moss, J.; Oliver, C. Prevalence of autism spectrum disorder phenomenology in genetic disorders: A systematic review and meta-analysis. Lancet Psychiatry 2015, 2, 909-916.
• Swedo, S.E. Autism Spectrum Disorder. In Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; American Psychiatric Association: Washington, DC, USA, 2013; pp. 50-59.
• Kanner, L. Autistic disturbances of affective contact. Nerv. Child 1943, 2, 217-250.

Terms in the title (7)： 共存 ,  知的障害 ,  自閉症 ,  サブ ,  クラス ,  オキシトシン ,  社会的相互作用